Clinical trial
Tolerability and Efficacy of CD+A Compared to AQ+SP for the Treatment of…
NCT00461578 · London School of Hygiene and Tropical Medicine, Other · Completed
Key facts
| NCT number | NCT00461578 |
|---|---|
| Title | Tolerability and Efficacy of CD+A Compared to AQ+SP for the Treatment of P.Falciparum Malaria in Rwandan Children |
| Official title | Open Study on the Tolerability and Efficacy of the Combination Chlorproguanil-Dapsone+Artesunate Compared to Amodiaquine+Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum Malaria in Rwandan Children |
| Lead sponsor | London School of Hygiene and Tropical Medicine, Other |
| Collaborators | Institute of Tropical Medicine, Belgium |
| Status | Completed |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Chlorproguanil-dapsone + artesunate |
| Enrollment | 800 |
| Start date | Apr 1, 2005 |
| Completion | Oct 1, 2006 |
| First posted | Apr 18, 2007 |
| Last update posted | Apr 18, 2007 |
| Countries | Rwanda |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: